Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study.

Katsanos KH, Tatsioni A, Pedersen N, Shuhaibar M, Ramirez VH, Politi P, Rombrechts E, Pierik M, Clofent J, Beltrami M, Bodini P, Freitas J, Mouzas I, Fornaciari G, Moum B, Lakatos PL, Vermeire S, Langholz E, Odes S, Morain CO, Stockbrügger R, Munkholm P, Tsianos EV.

J Crohns Colitis. 2011 Oct;5(5):430-42. doi: 10.1016/j.crohns.2011.04.013. Epub 2011 May 18. Erratum in: J Crohns Colitis. 2012 Feb;6(1):132-3.

PMID:
21939917
[PubMed - indexed for MEDLINE]
2.

Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.

Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV; EC-IBD Study Group.

Digestion. 2007;75(2-3):113-21. Epub 2007 Jun 26.

PMID:
17598963
[PubMed - indexed for MEDLINE]
3.

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.

Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.

Scand J Gastroenterol. 2009;44(1):46-55. doi: 10.1080/00365520801977568.

PMID:
18609187
[PubMed - indexed for MEDLINE]
4.

Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, Tsianos EV, Mouzas I, Schulz TB, Monteiro E, Clofent J, Odes S, Limonard CB, Stockbrügger RW, Russel MG.

Scand J Gastroenterol. 2000 Dec;35(12):1272-7.

PMID:
11199366
[PubMed - indexed for MEDLINE]
5.

Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates.

Wolters FL, van Zeijl G, Sijbrandij J, Wessels F, O'Morain C, Limonard C, Russel MG, Stockbrugger RW.

World J Gastroenterol. 2005 Dec 7;11(45):7152-8.

PMID:
16437663
[PubMed - indexed for MEDLINE]
Free Article
6.

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Bernstein CN, Blanchard JF, Rawsthorne P, Yu N.

Am J Gastroenterol. 2001 Apr;96(4):1116-22.

PMID:
11316157
[PubMed - indexed for MEDLINE]
7.

Cancer risk in patients with inflammatory bowel disease: a population-based study.

Bernstein CN, Blanchard JF, Kliewer E, Wajda A.

Cancer. 2001 Feb 15;91(4):854-62.

PMID:
11241255
[PubMed - indexed for MEDLINE]
8.

Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.

Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, Stockbrügger RW; European Collaborative Study Group On Inflammatory Bowel Disease.

Scand J Gastroenterol Suppl. 2006;(243):46-54.

PMID:
16782622
[PubMed - indexed for MEDLINE]
9.

5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.

Bernstein CN, Nugent Z, Blanchard JF.

Am J Gastroenterol. 2011 Apr;106(4):731-6. doi: 10.1038/ajg.2011.50. Epub 2011 Mar 15.

PMID:
21407180
[PubMed - indexed for MEDLINE]
10.

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease.

Munkholm P.

Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:1-5. Review.

PMID:
12950413
[PubMed - indexed for MEDLINE]
11.

The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.

Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A.

Eur J Gastroenterol Hepatol. 2008 Sep;20(9):917-23. doi: 10.1097/MEG.0b013e3282f97b33.

PMID:
18794607
[PubMed - indexed for MEDLINE]
12.

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL.

World J Gastroenterol. 2004 Feb 1;10(3):404-9.

PMID:
14760767
[PubMed - indexed for MEDLINE]
Free Article
13.

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M.

Gut. 1996 Nov;39(5):690-7.

PMID:
9014768
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M.

Rheumatol Int. 2006 May;26(7):663-8. Epub 2005 Sep 1.

PMID:
16136311
[PubMed - indexed for MEDLINE]
15.

Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.

Torres EA, De Jesús R, Pérez CM, Iñesta M, Torres D, Morell C, Just E.

P R Health Sci J. 2003 Sep;22(3):253-8.

PMID:
14619451
[PubMed - indexed for MEDLINE]
16.

Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

Jess T, Winther KV, Munkholm P, Langholz E, Binder V.

Aliment Pharmacol Ther. 2004 Feb 1;19(3):287-93.

PMID:
14984375
[PubMed - indexed for MEDLINE]
Free Article
17.

Extraintestinal cancers in inflammatory bowel disease.

Greenstein AJ, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, Aufses AH Jr.

Cancer. 1985 Dec 15;56(12):2914-21.

PMID:
4052961
[PubMed - indexed for MEDLINE]
18.

Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease.

Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A.

Inflamm Bowel Dis. 2006 Sep;12(9):879-84.

PMID:
16954807
[PubMed - indexed for MEDLINE]
19.

Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.

Kappelman MD, Farkas DK, Long MD, Erichsen R, Sandler RS, Sørensen HT, Baron JA.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):265-73.e1. doi: 10.1016/j.cgh.2013.03.034. Epub 2013 Apr 17.

PMID:
23602821
[PubMed - in process]
20.

Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

Söderlund S, Granath F, Broström O, Karlén P, Löfberg R, Ekbom A, Askling J.

Gastroenterology. 2010 May;138(5):1697-703. doi: 10.1053/j.gastro.2010.02.007. Epub 2010 Feb 16.

PMID:
20167217
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk